Skip to main content

Early day motion tabled by primary sponsor Liz Twist (Labour), on Monday, 24 November 2025, in the House of Commons. It is signed by 21 members in total.


Phenylketonuria awareness and access to treatment (No. 2)

That this House recognises the progress made in improving the care of people with phenylketonuria (PKU), a rare inherited metabolic disorder which prevents the body from properly metabolising phenylalanine; welcomes that many patients have benefitted from access to sapropterin, which has improved quality of life for some individuals living with PKU; notes, however, that significant unmet clinical needs remain, with many patients unable to benefit from existing treatments and still reliant on a highly restrictive diet; further recognises the continuing impact of PKU on patients, carers and families; and highlights the need for access to further innovative treatments and technologies that can improve outcomes and reduce the lifelong burden of PKU.


Secondary information

Type
Early day motion
Reference
2358 
Session
2024-26
Other sponsors
Wera Hobhouse
Jim Shannon
Brian Mathew
Ann Davies
Vikki Slade
Subjects
Access Health education Medical treatments Phenylketonuria
Link
View this Early day motion on edm.parliament.uk